{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Brain+Scan-PET&page=2", "query": { "intervention": "Brain Scan-PET", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Brain+Scan-PET&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-03T09:25:47.533Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01217021", "title": "Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "[18F] MNI-558", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Institute for Neurodegenerative Disorders", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 10, "start_date": "2010-09", "completion_date": "2011-03", "has_results": false, "last_update_posted_date": "2011-07-25", "last_synced_at": "2026-09-03T09:25:47.533Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01217021" }, { "nct_id": "NCT02911142", "title": "Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Primary Effusion Lymphoma", "B-Cell Neoplasm" ], "interventions": [ { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "CT of neck, chest, abdomen and pelvis", "type": "DIAGNOSTIC_TEST" }, { "name": "18FDG-PET scan", "type": "DIAGNOSTIC_TEST" }, { "name": "MRI Brain", "type": "DIAGNOSTIC_TEST" }, { "name": "Bone marrow biopsy", "type": "PROCEDURE" }, { "name": "EKG", "type": "DIAGNOSTIC_TEST" }, { "name": "Echocardiogram", "type": "DIAGNOSTIC_TEST" }, { "name": "Ultrasound", "type": "DIAGNOSTIC_TEST" }, { "name": "Bronchoscopy", "type": "DIAGNOSTIC_TEST" }, { "name": "Endoscopy", "type": "DIAGNOSTIC_TEST" }, { "name": "CXR: PA/lat/decub", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST", "PROCEDURE" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2017-07-03", "completion_date": "2028-10-01", "has_results": true, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-09-03T09:25:47.533Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02911142" }, { "nct_id": "NCT03082768", "title": "Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "[18F]MNI-968", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Molecular NeuroImaging", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 6, "start_date": "2017-03-03", "completion_date": "2018-03-01", "has_results": false, "last_update_posted_date": "2018-03-06", "last_synced_at": "2026-09-03T09:25:47.533Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03082768" }, { "nct_id": "NCT03903549", "title": "Initial Investigation of [18F]P17-059 in Parkinson's Disease Patients and Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "[18F]P17-059", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Five Eleven Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "45 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "45 Years to 90 Years" }, "enrollment_count": 4, "start_date": "2022-07-15", "completion_date": "2022-12-19", "has_results": false, "last_update_posted_date": "2023-01-11", "last_synced_at": "2026-09-03T09:25:47.533Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03903549" }, { "nct_id": "NCT03412604", "title": "Effect of Modulating Gamma Oscillations Using tACS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "Transcranial Alternating Current Stimulation (tACS)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 5, "start_date": "2018-08-02", "completion_date": "2019-09-15", "has_results": true, "last_update_posted_date": "2022-08-22", "last_synced_at": "2026-09-03T09:25:47.533Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03412604" }, { "nct_id": "NCT04311515", "title": "To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "Tau Positron emission tomography (PET)", "type": "RADIATION" }, { "name": "Fluorodeoxyglucose (FDG) Positron emission tomography (PET)", "type": "RADIATION" }, { "name": "Cerebrospinal fluid (CSF) Biomarkers", "type": "DIAGNOSTIC_TEST" }, { "name": "Blood Biomarkers", "type": "DIAGNOSTIC_TEST" }, { "name": "Rating Scales", "type": "BEHAVIORAL" }, { "name": "PU-AD", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DIAGNOSTIC_TEST", "BEHAVIORAL", "DRUG" ], "sponsor": "Samus Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "55 Years to 80 Years" }, "enrollment_count": 4, "start_date": "2020-06-30", "completion_date": "2022-11-15", "has_results": false, "last_update_posted_date": "2022-11-17", "last_synced_at": "2026-09-03T09:25:47.533Z", "location_count": 10, "location_summary": "Boca Raton, Florida • Delray Beach, Florida • Lake Worth, Florida + 6 more", "locations": [ { "city": "Boca Raton", "state": "Florida" }, { "city": "Delray Beach", "state": "Florida" }, { "city": "Lake Worth", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04311515" }, { "nct_id": "NCT03003715", "title": "Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Trigeminal Neuropathic Pain" ], "interventions": [ { "name": "PET Scans", "type": "PROCEDURE" }, { "name": "transcranial direct current stimulation (tDCS)", "type": "PROCEDURE" }, { "name": "MRI", "type": "PROCEDURE" }, { "name": "sham tDCS (prior to real tDCS)", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 13, "start_date": "2011-09", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2017-11-24", "last_synced_at": "2026-09-03T09:25:47.533Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03003715" }, { "nct_id": "NCT05849467", "title": "Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Progressive Multifocal Leukoencephalopathy", "Multiple Sclerosis", "Other Neuroinflammatory Diseases With BBB Leakage" ], "interventions": [ { "name": "89 Zr-Df-crefmirlimab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 15, "start_date": "2023-10-19", "completion_date": "2030-12-01", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-09-03T09:25:47.533Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05849467" }, { "nct_id": "NCT06129838", "title": "Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "[11C]-CS1P1", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 80, "start_date": "2023-05-05", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-06-09", "last_synced_at": "2026-09-03T09:25:47.533Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06129838" }, { "nct_id": "NCT02919332", "title": "Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Glioblastoma", "Glioma" ], "interventions": [ { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Fludeoxyglucose F-18", "type": "RADIATION" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "RADIATION" ], "sponsor": "Jonsson Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 0, "start_date": "2016-06-08", "completion_date": "2018-12-12", "has_results": false, "last_update_posted_date": "2020-07-24", "last_synced_at": "2026-09-03T09:25:47.533Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02919332" } ] }